Pentamethylcyclopentadienyl Ruthenium Complexes with Sulfur- and Selenium-Donor Ligands

Treatment of [Cp*Ru(NO)Cl2] (Cp* = η5-C5Me5) with NaQAr or LiQAr (Q = S, Se, Te; Ar = C6F4H or Ph) affords [Cp*Ru(NO)(QAr)2]. Interactions of [Cp*Ru(NO)(SC6F4H)2] with PR3 (R = Ph or Me) give [Cp*Ru(PR3)2(SC6F4H)] via phosphoraminate intermediates. The crystal structures of [Cp*Ru(NO)(SC6F4H)2] and...

Full description

Saved in:
Bibliographic Details
Published in:Organometallics 2001-08, Vol.20 (17), p.3777-3781
Main Authors: Zhang, Qian-Feng, Cheung, Florence K. M, Wong, Wai-Yeung, Williams, Ian D, Leung, Wa-Hung
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Treatment of [Cp*Ru(NO)Cl2] (Cp* = η5-C5Me5) with NaQAr or LiQAr (Q = S, Se, Te; Ar = C6F4H or Ph) affords [Cp*Ru(NO)(QAr)2]. Interactions of [Cp*Ru(NO)(SC6F4H)2] with PR3 (R = Ph or Me) give [Cp*Ru(PR3)2(SC6F4H)] via phosphoraminate intermediates. The crystal structures of [Cp*Ru(NO)(SC6F4H)2] and [Cp*Ru(PMe3)2(SC6F4H)] have been determined. Treatment of [Cp*Ru(MeCN)3][PF6] with HN[SeP(i-Pr)2]2 affords a novel Cp*Ru(IV) complex, [Cp*Ru{η2-Se2P(i-Pr)2}{η2-SeP(i-Pr)2}][PF6], which has been characterized by X-ray crystallography.
ISSN:0276-7333
1520-6041
DOI:10.1021/om010054x